The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 3, 2009, Pages 601-605

  Uygun, Kazim ^a   Bilici, Ahmet ^b,d   Karagol, Hakan ^c   Caloglu, Murat ^c   Cicin, Irfan ^c   Aksu, Gorkem ^a   Fayda, Merdan ^a   Uzunoglu, Sernaz ^c  

^a KOCAELI UNIVERSITY   (Turkey)

^b DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d Menderes Mah   (Turkey)

Author keywords

Cisplatin; Concurrent chemoradiotherapy; Inoperable head and neck cancer; Squamous cell; Three weekly; Weekly cisplatin

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HEAD AND NECK CANCER; HUMAN; INOPERABLE CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PERFORMANCE; PRIORITY JOURNAL; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67349144673     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0911-7     Document Type: Article

References (23)

1. J Bernier SM Bentzen 2003 Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology Eur J Cancer 39 560 571 (Pubitemid 36287367)
2. GK Beckman F Hoppe L Pfreundner MP Flentje 2005 Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer Head Neck 27 36 43 (Pubitemid 40024087)
3. Million RR, Cassisi NJ (1994) Management of head and neck cancer: a multidisciplinary approach. JB Lippincott, Philadelphia
4. DJ Adelstein Y Li GL Adams H Wagner Jr JA Kish JF Ensley DE Schuller AA Forastiere 2003 An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98
5. JP Pignon B Baujat J Bourhis 2005 Individual patient data meta-analyses in head and neck carcinoma: what have we learnt? Cancer Radiother 9 31 36 (Pubitemid 40445407)
6. W Van den Bogaert E van der Schueren JC Horiot M De Vilhena S Schraub V Svoboda G Arcangeli M de Pauw M Van Glabbeke 1995 The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects Radiother Oncol 35 91 99
7. Bernier J, Bentzen SM (2003) Head and neck cancer management: which postoperative treatment best serves your patient? In: 29th Annual meeting, American Society of Clinical Oncology, Educational Book, pp 306-312
8. JA Medina A Rueda AS de Pasos J Contreras M Cobo P Moreno M Benavides A Villanueva E Alba 2006 A phase II study of concomitant boast radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas Radiother Oncol 79 34 38
9. SN Geeta TK Padmanabhan J Samuel K Pavithran S Iyer MA Kuriakose 2006 Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers J Can Res Ther 2 100 104 (Pubitemid 44477530)
10. B Jeremic Y Shibamoto B Milicic N Nikolic A Dagovic J Aleksandrovic Z Vaskovic L Tadic 2000 Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial J Clin Oncol 18 1458 1464 (Pubitemid 30205391)
11. VA Marcial TF Pajak M Mohiuddin JS Cooper M al Sarraf PA Mowry W Curran J Crissman M Rodríguez E Vélez-García 1990 Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17 Cancer 66 1861 1868 (Pubitemid 20385952)
12. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG (2002) AJCC cancer staging manual, 6th edn. Springer, New York
13. AB Miller B Hoogstraten M Staquet A Winkler 1981 Reporting results of cancer treatment Cancer 47 207 214 (Pubitemid 11167383)
14. JD Cox JA Stetz TF Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 1346
15. DA Stephard 1976 The 1975 declaration of Helsinki and consent Can Med Assoc J 115 1191 1192
16. AS Glickman G Slotman C Doolittle 3rd J Clark J Koness N Coachman M Posner E DeRosa H Wanebo 1994 Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer Int J Radiat Oncol Biol Phys 30 1043 1050 (Pubitemid 24362512)
17. M Serin HS Erkal A Cakmak 1999 Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas Acta Oncol 38 1031 1035 (Pubitemid 30033025)
18. JE Byfield TR Sharp SS Frankel SG Tang FB Callipari 1984 Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck J Clin Oncol 2 406 413 (Pubitemid 14075969)
19. GP Browman C Cripps DI Hodson L Eapen J Sathya MN Levine 1994 Placebo-controlled randomized trial of infusional fluorouracil during standard RT in locally advanced head and neck cancer J Clin Oncol 12 2648 2653 (Pubitemid 24379652)
20. NK Gupta RC Pointon PM Wilkinson 1987 A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer Clin Radiol 38 575 581
21. BG Haffty YH Son R Papac CT Sasaki JB Weissberg D Fischer S Rockwell AC Sartorelli JJ Fischer 1997 Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of head and neck: results of the Yale mitomycin C randomized trials J Clin Oncol 15 268 276 (Pubitemid 27020583)
22. L Barzan A Veronesi G Caruso D Serraino D Magri V Zagonel U Tirelli R Comoretto S Monfardini 1990 Head and neck cancer and ageing: a retrospective study in 438 patients J Laryngol Otol 104 634 640 (Pubitemid 20263930)
23. AI Dreyfuss JR Clark 1991 Analysis of prognostic factors in squamous cell carcinomas of the head and neck Hematol Oncol Clin North Am 5 701 712